-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOHAVEN SHARES JUMP 45% PREMARKET AS FDA ACCEPTS RESUBMITTED APPLICATION FOR BRAIN DISORDER DRUG

Reuters·10/22/2026 11:42:14

Please log in to view news